Significance of suspicious lesions at transrectal ultrasonography in men with serum prostate-specific antigen levels of <20 ng/ml

被引:0
|
作者
Shim, Hong Bang
Lee, Sang Eun
Park, Hyoung Keun
Ku, Ja Hyeon
机构
[1] Seoul Vet Hosp, Dept Urol, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea
[3] DongGuk Univ Int Hosp, Dept Urol, Goyang, South Korea
来源
TUMORI JOURNAL | 2007年 / 93卷 / 02期
关键词
prostate biopsy; prostate neoplasms; prostate-specific antigen; transrectal ultrasonography;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims and background: The objective of the study was to evaluate the significance of suspicious lesions at transrectal ultrasonography for prostate cancer diagnosis. Patients and methods: A total of 1,009 men with a mean age of 65.0 +/- 7.7 years (range, 40.0-79.0) constituted the study cohort and 265 (26.3%) were diagnosed with prostate cancer on initial biopsy. Results: The cancer detection rate was higher in patients with suspicious lesions (33.2%) than in those with no suspicious lesion (21.5%) (P < 0.001). Pathologic findings of the needle biopsy samples also showed more aggressive characteristics in men with suspicious lesions (P < 0.05). Of 413 men with suspicious lesions, additional lesion-directed biopsies were performed in 133 patients. The positive predictive value of additional lesion-directed biopsy was 18.0%. Of patients who had positive cores on lesion-directed biopsies, all were also found to have positive cores on random biopsies, and no patient had positive cores only on lesion-directed biopsies. The Gleason score was not changed by the findings of lesion-directed biopsies in these patients. Conclusions: Our findings do not provide a rationale to recommend the addition of lesion-directed biopsy in patients with suspicious lesions at transrectal ultrasonography. However, men with suspicious lesions at transrectal ultrasonography had a higher risk of being diagnosed with prostate cancer.
引用
收藏
页码:178 / 181
页数:4
相关论文
共 50 条
  • [1] Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 ng/mL or less
    Yamamoto, T
    Ito, K
    Ohi, M
    Kubota, Y
    Suzuki, K
    Fukabori, Y
    Kurokawa, K
    Yamanaka, H
    [J]. UROLOGY, 2001, 58 (06) : 994 - 998
  • [2] Serum ribonuclease activity in the diagnosis of prostate cancer in men with serum prostate-specific antigen levels between 2.5 and 20 ng/mL
    Eskicorapci, SY
    Özkara, HA
    Önder, E
    Akdogan, B
    Erkan, I
    Ciliv, G
    Ozen, H
    [J]. CLINICAL BIOCHEMISTRY, 2006, 39 (04) : 363 - 366
  • [3] Effect of transrectal ultrasonography of the prostate on serum prostate-specific antigen levels and free/total prostate-specific antigen ratio
    Serel, TA
    Çetin, M
    Delibas, N
    Çelik, E
    Tahoglu, M
    [J]. UROLOGIA INTERNATIONALIS, 2000, 64 (01) : 24 - 26
  • [4] Tumour markers for managing men who present with metastatic prostate cancer and serum prostate-specific antigen levels of &lt;10 ng/mL
    Birtle, AJ
    Freeman, A
    Masters, JRW
    Payne, HA
    Harland, SJ
    [J]. BJU INTERNATIONAL, 2005, 96 (03) : 303 - 307
  • [5] Transrectal Saturation Technique May Improve Cancer Detection as an Initial Prostate Biopsy Strategy in Men with Prostate-specific Antigen &lt;10 ng/ml
    Li, Yong-Hong
    Elshafei, Ahmed
    Li, Jianbo
    Gong, Michael
    Susan, Luay
    Fareed, Khaled
    Jones, J. Stephen
    [J]. EUROPEAN UROLOGY, 2014, 65 (06) : 1178 - 1183
  • [6] Clinicopathologic Features of Patients with Serum Prostate-Specific Antigen Levels > 1000 ng/mL
    Horwath, Michael
    Oprea-Ilies, Gabriela
    Osunkoya, Adeboye
    [J]. LABORATORY INVESTIGATION, 2024, 104 (03) : S962 - S963
  • [7] A high serum dehydroepiandrosterone concentration is a predictor of candidates for active surveillance in men with serum prostate-specific antigen &lt; 10 ng/mL
    Miyoshi, Yasuhide
    Kawahara, Takashi
    Uemura, Hiroji
    [J]. BMC CANCER, 2022, 22 (01)
  • [8] Characterizing prostatic adenocarcinomas in men with a serum prostate specific antigen level of &lt;4.0 ng/mL
    Sokoloff, MH
    Yang, XJ
    Fumo, M
    Mhoon, D
    Brendler, CB
    [J]. BJU INTERNATIONAL, 2004, 93 (04) : 499 - 502
  • [9] The impact of prostate-specific antigen density in predicting prostate cancer when serum prostate-specific antigen levels are less than 10 ng/ml
    Akdas, A
    Tarcan, T
    Turkeri, L
    Cevik, I
    Biren, T
    Ilker, Y
    [J]. EUROPEAN UROLOGY, 1996, 29 (02) : 189 - 192
  • [10] Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less
    Morgentaler, Abraham
    Rhoden, Ernani Luis
    [J]. UROLOGY, 2006, 68 (06) : 1263 - 1267